Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
121 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
122 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
123 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ayat allah Ali yousseif 2021
124 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
125 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2021
126 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Duaa Abdel-Samia Mohamed Ali 2021
127 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
128 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2021
129 Chest CT features of COVID-19 pediatric patients presented with upper respiratory
symptoms
 		Department of Radiology Dr. Lamiaa Mohammed Refaat khalaf 2021
130 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021